CME Policy on Full Disclosure
The Alberta Psychiatric Association requires disclosure of the existence of ANY AND ALL financial interest(s) or other affiliation(s) a presenter has with commercial supporter(s) of these educational activities, and/or with manufacturer(s) of ANY AND ALL commercial product(s) and/or provider(s) of ANY AND ALL commercial services discussed in the scientific program. The existence of such relationships does not necessarily constitute a conflict of interest, but the prospective audience must be informed of the presenter’s affiliation with every commercial sponsor by way of an acknowledgement in program.
This policy is intended to openly identify any potential conflict(s) so that members of the audience in an educational activity are able to form their own opinions about the presentation. A reasonable test to guide decisions about what to disclose is whether any particular affiliation could cause embarrassment to the individual or institution involved or lead to questions about the presenter’s motives if such affiliation(s) were made known to the general public.
The following presenters have indicated a financial interest or other affiliation with a commercial supporter of the session and/or with the manufacturer(s) of a commercial product and/or provider of commercial service(s):
| Speaker | Co-Author | Affiliation |
| Nia Abdullayeva |
N/A |
|
| Jan Banasch |
Otsuka, Janssen |
|
| Cynthia Baxter |
Toddington International (associate), numerous private assessments but none related to medication, books, or any other profit-making sales |
|
| Joan Besant |
N/A |
|
| Sara Binder |
Takeda, Janssen, Elvium, Lundbeck, ICPDHM, Otsuka, Abbvie, Eisai - Speaker |
|
| Christoph Correll |
AbbVie, Acadia, Adock Ingram, Alkermes, Allergan, Angelini, Aristo, Biogen, Boehringer-Ingelheim, Bristol-Meyers Squibb, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Delpor, Denovo, Eli Lilly, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Jamjoom Pharma, Janssen/J&J, Karuna, Kuleon Biosciences, LB Pharma, Lundbeck, MedInCell, MedLink, Merck, Mindpax, Mitsubishi Tanabe Pharma, Maplight, Mylan, Neumora Therapeutics, Neurocrine, Neurelis, Newron, Noven, Novo Nordisk, Otsuka, PPD Biotech, Quantic, Recordati, Relmada, Reviva, Rovi, Sage, Saladax, Sanofi, Seqirus, SK Life Science, Sumitomo Pharma America, Sunovion, Sun Pharma, Supernus, Tabuk, Takeda, Teva, Terran, Tolmar, Vertex, Viatris and Xenon Pharmaceuticals |
|
| David Crockford | Trenna Norris |
N/A |
| Parker Dahl | Carl Adrian |
Esai Advisory Board |
| Ana Drandic |
Carewest Operational Stress Injury Clinic |
|
| Cassandra Felske-Durksen |
Alberta Medical Association Indigenous Health Committee - Chair |
|
| Payman Hajiazim |
Sleep and Wake Clinic, Medico Sleep Honoraria for advisory board activities: Sunovion, Paladin Honoraria for lectures: Novartis, Abbvie, Eisai, Paladin Participation in clinical trials: Flamel, Idorsia, Eisai |
|
| Jennifer Hibbard | Monique Jericho |
Standard physician arrangement with Recovery Alberta and U of C |
| Monica Hill |
N/A |
|
| Deena Hinshaw |
Employee of the Government of Alberta, Jan 2019 to Nov 2022 (salaried) Clinical faculty appointment in the Division of Preventive Medicine, Department of Medicine, School of Medicine and Dentistry, University of Alberta, July 2010 to present (no financial compensation) Contract work with the Government of British Columbia, Jan 2023 to Oct 2023 (hourly rate compensation) Employee of the Government of Canada, Indigenous Services Canada, Jan 2024 to present (salaried) |
|
| Omid Javizian | Dr. Rita Watterson |
|
| Zayna Khayat |
University of Toronto - adjunct faculty; Deloitte Canada - contractor; Talk Boutique - member of speaker's bureau; Teladoc Health Canada - contractor; Santis Health - expert advisor and I2U advisory board; Kudos - expert advisor; CADTH (Canadian Drug Agency) - expert advisor and AI advisory panel; PHAC - Type 2 Diabetes Challenge advisory panel PHSA (BC) - contractor Canada School of Policy - guest lecturer / contractor Rotman School of Management - Health Leadership Advisory Board |
|
| Atul Khullar | Otsuka, Lundbeck, Elvium, Takeda, Idorsia, Eisai, Bausch | |
| Maryana Kravtsenyuk | N/A | |
| Ahmed Ben Mabrouk | Maryana Kravtsenyuk | N/A |
| Usama Malik | Dr. Daniel Moreno De Luca |
Advisory Board Member - GATHER Foundation, Advisory Board Member - 17q12 Foundation CASA Research Chair. One Child Every Child grant from University of Calgary/University of Alberta Advisory Board Member - GATHER Foundation, Advisory Board Member - 17q12 Foundation GATHER Foundation, Advisory Board Member |
| Candice Monson | CIHR, Nellie Health | |
| Keely Murphy | Amanda Roze des Ordons | |
| Trenna Norris | David Crockford | N/A |
| Ric Procyshyn | AbbVie, Eisai, HLS, Janssen, Lundbeck, Otsuka | |
| Thomas Joseph Raedler |
Abbvie, Allergan, Biohaven, Boehringer Ingelheim, Otsuka, SyneuRx International, Newron |
|
| Roger Rampling |
N/A |
|
| David Rubin |
N/A |
|
| Rawel Sidhu | Dr. Serdar Dursun; Dr. Michael Demas |
N/A |
| Rob Tanguay | Dr. Anees Bahji, Dr. Valerie Primeau, Dr. Angie Hamilton, Dr. Philip Leger |
Rob Tanguay: The Newly Institute, Founder, Former CMO, Shareholder (No longer associated with company) Indivior: Moderated lunch session at CSAM conference
Dr. Anees Bahji: Canadian Institute of Health Research (CIHR) - Fellowship Award, Alberta Innovates - Doctoral Scholarship, Cumming School of Medicine, University of Calgary - Endowment Funding (Friends of Matt Newell and Leroy H. Le Riche Endowments), National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Canadian Psychiatric Association (CPA), American Psychiatric Association (AMA), Canadian Society of Addiction Medicine (CSAM), American Society of Addiction Medicine (ASAM), International Society of Addiction Medicine (ISAM) and College on Problems of Drug Dependence (CPDD)
Dr. Philip Leger: Docs for Decriminalization (a Canadian non-profit) Dr. Valerie Primeau: Canadian Academy of Addiction Psychiatry (CAAP) - Founding Director & Treasurer, Travel reimbursement for 2024 CAAP Conference |
| Leslie Truong | Dr. Jennifer Swainson, Dr. Carson Chrenek, Dr. Robert Tanguay, Dr. Esther Fujiwara |
Abbvie, Bausch, CIHR funding Eisai, Idorsia, Lundbeck, Novonordisk, Otsuka, Janssen The Newly Institute, Founder, Former CMO, Shareholder (No longer associated with company) Indivior: Moderated lunch session at CSAM conference CIHR team grant (unrelated to this study) |
| Maryna Turbinska | Dr. Maryana Kravtsenyuk |
N/A |
|
|
||
| Olga Winkler, Lisa Burback & Phillip Sevigny |
Olga Winkler: Alberta Mental Heath Foundations, Grant funding for HiMARC 3MDR research has been received from the Government of Canada Innovation for Defence Excellence and Security (IDEaS), the Government of Alberta, the Glenrose Rehabilitation Hospital Foundation, First Response to Fashion and the Royal Canadian Legion, Mental Health Foundation. Lisa Burback: Mental Health Foundation; Glenrose Rehabilitation Hospital Foundation, and the Royal Canadian Legion (research grants). Also received grants from Government of Alberta, Government of Canada. Phillip Sevigny: Supporting Military Members and Veterans through HiMARC, the 3MDR Study and the Military, Veteran and Family Connected Campus (MVFCC) (2023-05-15 to 2028-03-31) Brémault-Phillips, S., Greenshaw, A, Sevigny, P. R., Burback, L, Friese, K. (3.75 million over 5 years; Government of Alberta, Advanced Education) |
|
| Howie Wu | Iliana Ortega |
N/A |
| Siavash Zare-Zadeh |
Alberta Health Services |